Template:Central line with coagulopathy: Difference between revisions

No edit summary
No edit summary
Line 1: Line 1:
===[[Procedures in patients with coagulopathies|Coagulopathy]]===
===[[Procedures in patients with coagulopathies|Coagulopathy]]===
*If coagulopathic, use a compressible site such as the femoral location (avoid the IJ and Subclavian if possible)
*If [[Coagulopathy (Main)|coagulopathic]], use a compressible site such as the [[Central line: femoral|femoral]] location (avoid the [[Central line: internal jugular|IJ]] and [[Central line: subclavian|subclavian]] if possible)
*No benefit FFP unless you lacerate an artery<ref>Fisher NC, Mutimer DJ. Central venous cannulation in patients with liver disease and coagulopathy—a prospective audit. Intens Care Med 1999; 25:5</ref>
*No benefit [[FFP]] unless you lacerate an artery<ref>Fisher NC, Mutimer DJ. Central venous cannulation in patients with liver disease and coagulopathy—a prospective audit. Intens Care Med 1999; 25:5</ref>
**However, consider giving FFP if patient has [[Hemophilia|hemophilia]]<ref>Morado M.et al. Complications of central venous catheters in patients with haemophilia and inhibitors. Haemophilia 2001; 7:551–556</ref>
**However, consider giving [[FFP]] if patient has [[Hemophilia|hemophilia]]<ref>Morado M.et al. Complications of central venous catheters in patients with haemophilia and inhibitors. Haemophilia 2001; 7:551–556</ref>

Revision as of 19:59, 11 January 2015

Coagulopathy

  1. Fisher NC, Mutimer DJ. Central venous cannulation in patients with liver disease and coagulopathy—a prospective audit. Intens Care Med 1999; 25:5
  2. Morado M.et al. Complications of central venous catheters in patients with haemophilia and inhibitors. Haemophilia 2001; 7:551–556